WO2012059090A4 - Etacrynsäure zur verwendung bei der behandlung von lebensmittelempfindlichkeitsstörungen - Google Patents
Etacrynsäure zur verwendung bei der behandlung von lebensmittelempfindlichkeitsstörungen Download PDFInfo
- Publication number
- WO2012059090A4 WO2012059090A4 PCT/DE2011/001953 DE2011001953W WO2012059090A4 WO 2012059090 A4 WO2012059090 A4 WO 2012059090A4 DE 2011001953 W DE2011001953 W DE 2011001953W WO 2012059090 A4 WO2012059090 A4 WO 2012059090A4
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- etacrynic acid
- food sensitivity
- sensitivity disorders
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Erfindung betrifft die Verwendung von Etacrynsäure der Formel (I) zur Prophylaxe und Behandlung von Lebensmittelempfindlichkeitsstörungen, Lebensmittelunverträglichkeiten und Hauterkrankungen und insbesondere von Zöliakie sowie Zusammensetzungen enthaltend Etacryinsäure.
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102010050449.1 | 2010-11-03 | ||
DE102010050449A DE102010050449A1 (de) | 2010-11-03 | 2010-11-03 | Verwendung von Etacrynsäure zur Behandlung von Lebensmittelempfindlichkeitsstörungen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012059090A1 WO2012059090A1 (de) | 2012-05-10 |
WO2012059090A4 true WO2012059090A4 (de) | 2012-06-28 |
Family
ID=45528858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2011/001953 WO2012059090A1 (de) | 2010-11-03 | 2011-11-02 | Etacrynsäure zur verwendung bei der behandlung von lebensmittelempfindlichkeitsstörungen |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102010050449A1 (de) |
WO (1) | WO2012059090A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10016379B2 (en) | 2015-10-30 | 2018-07-10 | Robin L. Webb | Method of treatment for third spacing |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686100A (en) * | 1994-11-22 | 1997-11-11 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
US20040220264A1 (en) * | 2003-03-17 | 2004-11-04 | Yu Ruey J | Bioavailability and improved delivery of acidic pharmaceutical drugs |
WO2004104022A2 (en) * | 2003-05-16 | 2004-12-02 | The General Hospital Corporation | Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin a3), inhibitors thereof and methods of use thereof |
US20110003747A1 (en) * | 2007-07-20 | 2011-01-06 | Coloumbe Pierre A | Use of nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
-
2010
- 2010-11-03 DE DE102010050449A patent/DE102010050449A1/de not_active Ceased
-
2011
- 2011-11-02 WO PCT/DE2011/001953 patent/WO2012059090A1/de active Application Filing
Also Published As
Publication number | Publication date |
---|---|
DE102010050449A1 (de) | 2012-05-03 |
WO2012059090A1 (de) | 2012-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2418945A4 (de) | Mineralsalz-schwefelsäure-zusammensetzungen und verfahren zu ihrer verwendung | |
PH12015501965A1 (en) | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor | |
MY164731A (en) | Compound | |
UA110347C2 (uk) | ПОХІДНІ 6-ЦИКЛОАЛКІЛ-1,5-ДИГІДРОПІРАЗОЛО[3,4-d]ПІРИМІДИН-4-ОНУ І ЇХ ЗАСТОСУВАННЯ ЯК ІНГІБІТОРІВ PDE9A | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
WO2014028600A3 (en) | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
UA109667C2 (xx) | Похідні хіназолін-4(3h)-ону, що використовуються як інгібітори pi3-кінази | |
WO2012068109A3 (en) | Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof | |
EA201201030A1 (ru) | 5-алкинилпиримидины | |
MX2013005356A (es) | Uso de fluopyram para combatir nematodos en cultivos. | |
MX2015010125A (es) | Derivados de piridazinona-amidas. | |
EA202091303A2 (ru) | Композиция ингибитора jak для местного применения | |
UA95105C2 (ru) | Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения | |
IN2012DN01453A (de) | ||
TW200724532A (en) | Pyrimidinecarboxylic acid derivatives and their use | |
MX2011013032A (es) | Inhibidores de fosfatidilinositol 3-cinasa. | |
WO2013061004A8 (fr) | Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines | |
EP3587400A3 (de) | Verfahren zur herstellung eines pde4-inhibitors | |
EP3747457A3 (de) | Faktor-1-protein, faktor-2-protein und inhibitoren davon zur verwendung bei der behandlung und prävention von erkrankungen | |
CA2819007A1 (en) | 6-deoxy-6-thioether-amino acid cyclodextrin derivatives and preparation method thereof | |
MY150931A (en) | Substituted oxazolidinones and their use | |
MX2022007351A (es) | Derivados de 3-(5-metoxi-1-oxoisoindolin-2-il)piperidin-2,6-diona y usos de los mismos. | |
ATE380188T1 (de) | Substituierte chinolone | |
IN2012DN00953A (de) | ||
MX2011008645A (es) | Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11811518 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1120111042507 Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11811518 Country of ref document: EP Kind code of ref document: A1 |